OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost Effectiveness of Strategies to Manage Atrial Fibrillation in Middle- and High-Income Countries: A Systematic Review
Charles Okafor, Joshua Byrnes, Simon Stewart, et al.
PharmacoEconomics (2023) Vol. 41, Iss. 8, pp. 913-943
Open Access | Times Cited: 5
Charles Okafor, Joshua Byrnes, Simon Stewart, et al.
PharmacoEconomics (2023) Vol. 41, Iss. 8, pp. 913-943
Open Access | Times Cited: 5
Showing 5 citing articles:
The COOL-AF Phase 2 Registry
Rungroj Krittayaphong, Arjbordin Winijkul, Voravut Rungpradubvong, et al.
JACC Asia (2025) Vol. 5, Iss. 1, pp. 191-202
Open Access | Times Cited: 2
Rungroj Krittayaphong, Arjbordin Winijkul, Voravut Rungpradubvong, et al.
JACC Asia (2025) Vol. 5, Iss. 1, pp. 191-202
Open Access | Times Cited: 2
Fibrinaloid Microclots and Atrial Fibrillation
Douglas B. Kell, Gregory Y.H. Lip, Etheresia Pretorius
Biomedicines (2024) Vol. 12, Iss. 4, pp. 891-891
Open Access | Times Cited: 5
Douglas B. Kell, Gregory Y.H. Lip, Etheresia Pretorius
Biomedicines (2024) Vol. 12, Iss. 4, pp. 891-891
Open Access | Times Cited: 5
Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial
Zainab Abdali, Karina V Bunting, Samir Mehta, et al.
Heart (2025), pp. heartjnl-324761
Closed Access
Zainab Abdali, Karina V Bunting, Samir Mehta, et al.
Heart (2025), pp. heartjnl-324761
Closed Access
Fibrinaloid Microclots and Atrial Fibrillation
Douglas B. Kell, Gregory Y.H. Lip, Etheresia Pretorius
(2024)
Open Access | Times Cited: 4
Douglas B. Kell, Gregory Y.H. Lip, Etheresia Pretorius
(2024)
Open Access | Times Cited: 4
Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada
Aneeka Hafeez, Lauren E. Cipriano, Richard B. Kim, et al.
PharmacoEconomics (2023) Vol. 42, Iss. 1, pp. 69-90
Closed Access | Times Cited: 3
Aneeka Hafeez, Lauren E. Cipriano, Richard B. Kim, et al.
PharmacoEconomics (2023) Vol. 42, Iss. 1, pp. 69-90
Closed Access | Times Cited: 3
